Light Age Botox
Extraction of the most stable 900kD protein with 99.5% purity

By Hugel Patented Purification Method
Patent Number: 10-2017-003176

High Quality

Demands stricter QC standards than the Korean Food and Drug Administration

High Standard

The entire process is protected by patents, ensuring complete extraction of high purity products and ensuring quality stability through layers of quality control.

High Efficiency

Shorter treatment time
Faster treatment results

Letybo Frozen Crystal Injection, also known as Botox in Korea, is manufactured in Korea and was approved for sale by the Taiwan Ministry of Health and Welfare in 2019.
The injection needle is fine, and the treatment time is relatively short, which does not affect daily life. It is a non-invasive procedure, which is relatively safe, and is suitable for Asian people.

Frown lines (MFDS)

Letybo injection has an efficacy rate 7.45% higher than the control group after 4 weeks of treatment.

Crow's feet (MFDS)

Letybo injection has an efficacy rate 1.42% higher than the control group after 4 weeks of treatment.

Blepharospasm (MFDS)

Letybo injection has an efficacy rate 0.9% higher than the control group after 4 weeks of treatment.

remember the past

Can be used as a new option

for treating moderate to severe glabellar lines

Trial Design:

Double-blind, randomized, active-controlled, multicenter phase III clinical trial were conducted.

(Tri-Service General Hospital, Chang Gung Memorial Hospital in Linkou, Taipei, and Cathay General Hospital)

Present high satisfaction to medical beauty patients

To achieve the lowest possible pH value with minimal pain, Letybo maintains a balanced range of values.

2016-2020

No.1 in domestic sales in Korea
for 5 consecutive years.

Scroll to Top